A randomized, double blind, placebo-controlled, parallel group study to demonstrate the subjective treatment effects of ramelteon on sleep using a post sleep questionnaire - Interactive Voice Response System (PSQ-IVRS) in an 'at-home setting' in an adult population with chronic insomnia
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 25 Jun 2008 The expected completion date for this trial is now 1 Nov 2007.
- 12 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2007 New trial record.